Role of efflux pumps and metabolising enzymes in drug delivery
- 1 July 2005
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Delivery
- Vol. 2 (4) , 683-705
- https://doi.org/10.1517/17425247.2.4.683
Abstract
The impact of efflux pumps and metabolic enzymes on the therapeutic activity of various drugs has been well established. The presence of efflux pumps on various tissues and tumours has been shown to regulate the intracellular concentration needed to achieve therapeutic activity. The notable members of efflux proteins include P-glycoprotein, multi-drug resistance protein and breast cancer resistance protein. These efflux pumps play a pivotal role not only in extruding xenobiotics but also in maintaining the body’s homeostasis by their ubiquitous presence and ability to coordinate among themselves. In this review, the role of efflux pumps in drug delivery and the importance of their tissue distribution is discussed in detail. To improve pharmacokinetic parameters of substrates, various strategies that modulate the activity of efflux proteins are also described. Drug metabolising enzymes mainly include the cytochrome P450 family of enzymes. Extensive drug metabolism due to the this family of enzymes is the l...Keywords
This publication has 207 references indexed in Scilit:
- Steroid hormone biotransformation and xenobiotic induction of hepatic steroid metabolizing enzymesChemico-Biological Interactions, 2004
- The Product of the ABC Half-Transporter Gene ABCG2 (BCRP/MXR/ABCP) Is Expressed in the Plasma MembraneBiochemical and Biophysical Research Communications, 2000
- ABC-ATPases, adaptable energy generators fuelling transmembrane movement of a variety of molecules in organisms from bacteria to humansJournal of Molecular Biology, 1999
- Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteersBritish Journal of Clinical Pharmacology, 1998
- Concomitant use of selective serotonin reuptake inhibitors with other cytochrome P450 2D6 or 3A4 metabolized medications: how often does it really happen?Journal of Affective Disorders, 1997
- The P-glycoprotein multidrug transporterGeneral Pharmacology: The Vascular System, 1996
- MDR1 expression correlates with mutantp53 expression in colorectal cancer metastasesZeitschrift für Krebsforschung und Klinische Onkologie, 1996
- MDR1/P-glycoprotein in haematological neoplasmsEuropean Journal Of Cancer, 1996
- The nitrogen of the acetamido group of colchicine modulates P-glycoprotein-mediated multidrug resistanceBiochemistry, 1993
- Reversal of multi‐drug resistance in human KB cell lines by structural analogs of verapamilInternational Journal of Cancer, 1990